Skip to content

Comparison of myopia progression in different power of low intensity red light in children and adolescents

Comparison of myopia progression in different power of low intensity red light in children and adolescents

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058615
Enrollment
Unknown
Registered
2022-04-12
Start date
2022-04-15
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Low level red light group:The enrolled children were randomly divided into three low-intensity red light groups with different powers (650nm, 0.37mw ± 0.02mw
650nm, 0.6mW ± 0.2mw
650nm, 1.2MW), irradiating their eyes twice a day for 3 minutes each time, with an interval of = 4 hours
Maintenance treatment for 6 months.
Single focus glasses group:Only wear single focus glasses and observe for 6 months

Sponsors

Xuzhou No.1 People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 15 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion age: 6-15 years; 2. Monocular myopia or binocular myopia; The equivalent spherical mirror is between -0.50d and -6.00d; Astigmatism is less than 2.50d; 3. Best corrected visual acuity = 0.8; 4. No eye diseases such as strabismus and amblyopia; There were no systemic congenital diseases and organic lesions. 5. Those who voluntarily give up other treatment methods during the study shall voluntarily use the product according to the regulations and be able to cooperate with the doctor's examination; 6. Parents agree to be randomly divided into groups and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Have used myopia prevention and control measures (low concentration atropine, corneal plastic lens) within two months; 2.Patients who has surgery history and diabetes, hypertension systemic systemic disease; 3.Suffering from eye diseases that affect the morphology of fundus, such as retinal detachment, retinal splitting, proliferation of retinal pigment epithelium, uveitis, congenital fundus development defects, etc; 4. Congenital glaucoma; 5. Patients with halo; 6. Those who are cured of TiC; 7. ADHD cured; 8. Patients with psoriasis; 9. Patients with high intraocular pressure.

Design outcomes

Primary

MeasureTime frame
Change of axial length (AL);Change of equivalent spherical refraction (SE);

Secondary

MeasureTime frame
Change of uncorrected visual acuity (UCVA);Change of sub-foveal choroidal thickness (SFChT);

Countries

China

Contacts

Public ContactWang xiaojuan

Xuzhou No.1 people's Hospital

153803468@qq.com+86 15852260552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026